35 articles
Bayer's Monsanto unit urged a Missouri judge to approve a $7.25 billion settlement resolving thousands of Roundup cancer lawsuits. The company denies glyphosate causes cancer but seeks to resolve the
Bayer seeks Missouri court approval for a $7.25 billion settlement to resolve tens of thousands of Roundup cancer lawsuits, aiming to conclude years of litigation over the herbicide glyphosate.
The Trump administration plans to announce new drug-pricing agreements with major pharmaceutical firms like Bayer and Takeda, aiming to lower costs to match international levels. These deals could sav
Extreme European heat disrupts logistics and production for chemicals, agriculture, and food firms like BASF and Bayer, driving investment toward climate resilience solutions.
Bayer maintained its 2026 outlook after reporting Q2 earnings that exceeded estimates, driven by improved performance while monitoring external market dynamics.
Bayer reported an unexpected 1.9% rise in Q2 adjusted profit driven by strong seed technology sales and reduced legal risks from Roundup rulings. The company also lowered its net debt forecast followi
Bayer secured a €3 billion equity investment from Apollo Fund for its LARC business, granting Apollo a minority stake while retaining operational control. The deal is set to close in Q3 2026 pending r
Bayer secured a major Supreme Court victory limiting glyphosate lawsuits, while the EPA re-approved dicamba and cleared atrazine for endangered species, marking a significant regulatory shift favoring
Bayer secured €3 billion in equity from Apollo for its contraceptives unit, retaining majority control to strengthen its balance sheet against upcoming bond maturities. The transaction is expected to
Bayer aims to dismiss nearly 4,000 federal Roundup cancer lawsuits following a U.S. Supreme Court ruling on warning labels, while a separate $7.25 billion state court settlement remains pending for ov
The CW75 index gained 2.16% weekly, outperforming MSCI and S&P500, while Bayer shares rose after a U.S. Supreme Court ruling favored the company in the Monsanto litigation.
Bayer is consolidating its U.S. glyphosate operations into its Ruveon unit after requesting tariffs on Chinese imports to address sustainability concerns. This restructuring aims to create a more nimb
Bayer petitioned U.S. authorities to impose duties on cheaper Chinese glyphosate imports, claiming predatory pricing threatens its domestic business. The move follows a Supreme Court victory on liabil
The US Supreme Court ruled that federal law preempts state warning label requirements for Roundup, blocking thousands of lawsuits against Bayer. Despite the victory, Bayer plans to proceed with a prop
The US Supreme Court ruled 7–2 that states cannot mandate additional pesticide warnings beyond EPA approvals under FIFRA. This decision impacts Bayer following a Missouri jury's liability finding rega
Bayer shares surged 17.3%, their biggest jump since 2003, after the U.S. Supreme Court ruled in favor of the company regarding Roundup weedkiller lawsuits. The decision limits thousands of state cases
The CW75 index declined 2.06% last week, underperforming global markets, while Bayer shares increased following expectations of a US Supreme Court ruling on the Monsanto Co. v. Durnell case.
The European Parliament approved a new regulatory framework enabling the cultivation of gene-edited crops, marking a major shift from restrictive GMO rules. Implementation begins in mid-2028 following
Bayer partners with BP to commercialize Camelina-based biofuels like sustainable aviation fuel, planning millions of acres in North America. This initiative targets second-generation feedstocks that a
Bayer aims to expedite North American camelina production for biofuels following the Iran conflict-driven surge in fossil fuel prices. The company plans to meet mid-2030s targets earlier through new a
Major European chemical firms like BASF and Bayer maintain 2026 earnings guidance despite geopolitical risks. Strong Q2 demand and price hikes offset concerns over supply chain disruptions and rising
Bayer confirmed it has no plans to spin off Monsanto despite thousands of Roundup lawsuits. CEO Bill Anderson warned that unresolved glyphosate litigation could halt US production, as the company purs
Bayer plans to oppose transferring its Missouri Roundup class settlement case to a California federal court, insisting the venue should remain in state court. The company stated the transfer order has
Latham Quality sued Bayer for allegedly monopolizing the U.S. GMO corn seed market via anti-competitive practices regarding NK603 traits. Bayer denies the claims, maintaining its agricultural markets
Bayer India posted a 13.1% quarterly profit increase to 1.62 billion rupees, driven by strong herbicide and pesticide sales despite weaker corn seed demand. Revenue grew 5.2% amid challenges from infl
Bayer and BP partner to scale Camelina biofuel production, combining seed tech and refining expertise to meet rising demand for renewable fuels like sustainable aviation fuel by 2040.
Bayer confirmed its 2026 financial guidance after Q1 net profit more than doubled to €2.76 billion, beating analyst estimates. Strong crop science performance offset forex headwinds.
Bayer announced plans to acquire biopharmaceutical firm Perfuse Therapeutics for up to $2.45 billion to bolster its ophthalmology pipeline. The deal includes a $300 million upfront payment plus additi
The US Supreme Court heard oral arguments in a case concerning Bayer and Monsanto's liability for glyphosate-based Roundup, addressing potential state law warnings for cancer risks absent federal mand
The U.S. Supreme Court hears arguments in Bayer's bid to limit Roundup cancer lawsuits based on federal labeling preemption. A ruling could impact liability for tens of thousands of cases alongside th
ChemBrief